查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933359

全球标准胰岛素笔针市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考量、未来预测（2026-2034）

Standard Pen Needles Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 请询问到货日

价格

标准胰岛素笔针市场成长因素

预计2025年全球标准胰岛素笔针市场规模将达到16.5亿美元，2026年将成长至17.4亿美元，到2034年将达到30.7亿美元，预测期内复合年增长率（CAGR）为7.31%。北美地区将引领市场，2025年将占66%的市场占有率，这主要得益于该地区糖尿病的高发生率、完善的胰岛素注射基础设施以及胰岛素笔作为传统注射器的广泛应用。标准胰岛素笔针是一种与胰岛素笔和其他注射药物配合使用的医疗器械，可实现皮下注射。它们能够实现无痛、精准、便捷的自我注射，因此在糖尿病管理中尤其重要。 诺和诺德 (Novo Nordisk A/S)、BD 和 Embector 等主要市场参与者正专注于技术创新、策略联盟和大规模投资，以保持其市场领先地位。

市场动态

驱动因素：全球糖尿病盛行率的不断上升是推动市场发展的关键因素。根据国际糖尿病联盟 (IDF) 2023 年的数据，超过 5.3 亿成年人患有糖尿病，预计未来几十年这一数字将继续增长。胰岛素笔因其便携性和易用性而受到老年人和视力障碍患者的青睐，其日益普及也推动了市场发展。政府和非政府组织为改善胰岛素和胰岛素笔针的可及性而采取的举措，以及进行的糖尿病管理宣传活动，也促进了市场成长。 例如，2024年8月，Breakthrough T1D发起了 "检测，才能做决定" 活动，旨在促进第1型糖尿病的早期发现。

限制因素：针头恐惧症、注射方案依从性差以及胰岛素笔针头的重复使用阻碍了市场成长。在全球范围内，28%的糖尿病患者表示害怕针头，导致漏服药物和血糖控制不佳。认知度低和缺乏强有力的报销政策，尤其是在新兴市场，限制了胰岛素笔针头的进一步普及。

机会：在亚洲、拉丁美洲和非洲的中等收入国家扩大市场准入提供了巨大的机会。这些地区糖尿病盛行率的上升、城市化进程以及医疗基础设施的改善，正在推动对经济实惠、易于使用的胰岛素笔针头的需求。 2025年6月，无国界医生组织（MSF）对诺和诺德承诺以每支1美元的价格向南非供应胰岛素笔表示欢迎，这标誌着改善胰岛素笔可及性的努力正在不断扩大。

挑战：新兴市场自动注射器和其他先进给药系统的普及率仍然较低，这仍然是一个挑战。在中国和印度等国家，高昂的成本和缺乏报销政策阻碍了这些新型设备的普及。

市场趋势

技术创新正在重塑市场。製造商正在开发超细、短针头的注射笔，并采用先进的润滑和安全设计，以减轻疼痛和焦虑。可伸缩或有防护罩的针头提高了护理人员的安全性。能够记录和传输胰岛素剂量的智慧注射笔越来越受欢迎，以提高用药依从性和疾病管理。例如，2022年9月，泰尔茂株式会社在印度推出了 "FineGlide" 无菌注射笔针头，强调病患的舒适度和与自我注射疗法的兼容性。

市场区隔分析

依药物类型划分：2024年，胰岛素类药物占市场主导地位，主要得益于第1型糖尿病和晚期第2型糖尿病的长期治疗需求。 GLP-1类药物则位居第二，主要得益于处方量的成长和核准药物的扩大（例如，Biocon Limited于2025年2月在英国推出利拉鲁肽，用于治疗肥胖症和糖尿病）。

依疾病区分：糖尿病是推动市场成长的主要因素，这主要归功于注射疗法的广泛需求。肥胖症市场预计将快速成长，这主要得益于全球肥胖症盛行率的上升以及相应注射疗法的广泛应用。

依针头尺寸划分：2024年，4毫米针头占主导地位，这主要归功于其舒适性、降低肌肉注射风险以及医生的偏好。 6毫米针头市场预计将会成长，这主要得益于高BMI成人和肥胖患者的使用量增加。

依分销管道划分：由于便利性和可及性，零售药局在2024年占了最大的市场占有率，但由于送货上门服务、订阅模式和数位医疗的扩展，预计线上药局将成长最快。

区域展望

北美：由于糖尿病的高发生率和成熟的胰岛素输注系统，预计2025年市场规模将达到6.3亿美元。强而有力的报销政策促使注射笔在美国广泛应用，而加拿大家庭医疗保健机构的使用率也不断提高。

欧洲：在自我注射疗法意识不断提高和有利的医疗保健政策的支持下，欧洲正在占相当大的市场占有率。 2024年，英国开出了7,100万张糖尿病管理处方。

亚太地区：由于糖尿病患者人数的增加、城市化进程的加速以及医疗保健服务的改善，预计该地区将实现最高的成长率。 监管部门的批准，例如诺和诺德的诺和锐在中国获批（2022年），正在推动市场扩张。

拉丁美洲、中东和非洲：预计将保持稳定成长。巴西、墨西哥、沙乌地阿拉伯和阿拉伯联合大公国等国家正面临糖尿病盛行率上升、政府措施增加以及医疗基础设施不断完善等议题。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要公司新产品发布
  • 主要产业趋势：併购、业务合作等
  • 生物製药製造技术进步

第五章：全球标准注射笔针市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依药物类型划分
    • 胰岛素
    • GLP-1
    • 生长激素
    • 其他
  • 市场分析、洞察与预测：依疾病划分
    • 糖尿病
    • 肥胖症
    • 荷尔蒙缺乏症
    • 其他
  • 市场分析、洞察与预测：依针头尺寸划分
    • 4毫米
    • 5毫米
    • 6毫米
    • 8毫米
    • 12毫米
  • 市场分析、洞察与预测：依通路划分
    • 医院药房
    • 零售药房
    • 线上药房
  • 市场分析，洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美标准注射笔针市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲标准注射笔针市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

章节第八章：亚太地区标准注射笔针市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲标准注射笔针市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章：中东与非洲标准注射笔针市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会（海湾合作委员会）国家
    • 南非
    • 其他中东和非洲国家

第十一章：竞争分析

  • 全球市占率分析（2025 年）
  • 公司简介
  • Embecta Corp.
  • Cardinal Health
  • MTD Medical Technology and Devices
  • UltiMed, Inc.
  • Allison Medical, Inc.
  • Owen Mumford
  • Medline Industries, LP
  • B. Braun SE
  • Neon Diagnostics Limited
  • Other Prominent Players
Product Code: FBI113830

Growth Factors of standard pen needles Market

The global standard pen needles market was valued at USD 1.65 billion in 2025 and is projected to grow to USD 1.74 billion in 2026, reaching USD 3.07 billion by 2034, at a CAGR of 7.31% during the forecast period. North America dominated the market in 2025 with a 66% share, supported by high diabetes prevalence, well-established insulin delivery infrastructure, and widespread adoption of insulin pens over traditional syringes. Standard pen needles are medical devices used with insulin pens and other injectable medications for subcutaneous delivery, offering painless, precise, and convenient self-administration, which is particularly beneficial in diabetes management. Key market players, including Novo Nordisk A/S, BD, and Embecta Corp., are focusing on technological innovations, strategic collaborations, and extensive investments to maintain market leadership.

Market Dynamics

Drivers: The rising global prevalence of diabetes is the primary driver for the market. According to the International Diabetes Federation (IDF) 2023, over 530 million adults were living with diabetes, with numbers expected to rise in the coming decades. The growing adoption of insulin pens, favored for their portability and ease of use, especially among elderly and visually impaired patients, further drives the market. Initiatives by governments and NGOs to improve access to insulin and pen needles, along with campaigns to raise awareness about diabetes management, also contribute to market growth. For example, in August 2024, Breakthrough T1D launched the campaign "Detect so you can decide" to promote early Type 1 diabetes detection.

Restraints: Needle phobia, poor compliance with injection protocols, and reuse of pen needles hamper market growth. Globally, 28% of diabetic patients reportedly suffer from needle phobia, leading to skipped doses and poor glycemic control. Limited awareness and lack of strong reimbursement policies, especially in emerging markets, further restrict adoption.

Opportunities: Expanding market access in middle-income countries across Asia, Latin America, and Africa provides a significant opportunity. Rising diabetes prevalence, urbanization, and improved healthcare infrastructure in these regions drive demand for cost-effective and user-friendly pen needles. In June 2025, Medecins Sans Frontieres (MSF) welcomed Novo Nordisk's initiative to supply insulin pens to South Africa at USD 1 per pen, reflecting growing accessibility efforts.

Challenges: Limited penetration of autoinjectors and other advanced drug delivery systems in emerging markets remains a challenge. Higher costs and lack of reimbursement policies in countries like China and India reduce adoption of these novel devices.

Market Trends

Technological innovations are reshaping the market. Manufacturers are developing ultra-fine, short-length pen needles with advanced lubrication and safety-engineered designs to reduce pain and anxiety. Devices with retractable or shielded needles enhance caregiver safety. Smart pens with digital integration, capable of recording and transmitting insulin doses, are gaining popularity to improve adherence and disease management. For instance, in September 2022, Terumo Corporation launched the FineGlide sterile pen needle in India, emphasizing patient comfort and compatibility with self-administered insulin therapy.

Segmentation Analysis

By Drug Type: The insulin segment dominated in 2024, driven by long-term therapy for Type 1 and advanced Type 2 diabetes. The GLP-1 segment held the second-largest share, with growth supported by rising prescriptions and approvals, such as Biocon Limited's Liraglutide launch in February 2025 for obesity and diabetes treatment in the U.K.

By Disease Indication: Diabetes leads the market due to widespread injectable therapy requirements. The obesity segment is expected to grow rapidly with increasing global prevalence and adoption of compatible injectable therapies.

By Needle Size: The 4 mm needle dominated in 2024 due to comfort, reduced risk of intramuscular injection, and physician preference. The 6 mm needle segment is projected to grow, driven by use in adults with higher BMI or obesity.

By Distribution Channel: Retail pharmacies held the largest market share in 2024, offering convenience and accessibility, while online pharmacies are expected to grow fastest due to home delivery, subscription models, and digital health expansion.

Regional Outlook

North America: Market size reached USD 0.63 billion in 2025, driven by high diabetes prevalence and well-established insulin delivery systems. In the U.S., pen injectors benefit from strong reimbursement policies, while Canada is seeing rising adoption in home care.

Europe: Holds a significant share, supported by increasing awareness of self-injection therapies and favorable healthcare policies. In the U.K., 71 million items were prescribed for diabetes management in 2024.

Asia Pacific: Expected to grow at the fastest rate due to rising diabetes, urbanization, and healthcare access improvements. Regulatory approvals, such as Novo Nordisk's Novopen in China (2022), drive market expansion.

Latin America & Middle East & Africa: Steady growth is anticipated. Countries like Brazil, Mexico, Saudi Arabia, and UAE are witnessing rising diabetes prevalence, government-led initiatives, and expanding healthcare infrastructure.

Competitive Landscape

The market is fragmented, with key players including Embecta Corp., Cardinal Health, MTD Medical Technology and Devices, UltiMed, Inc., Owen Mumford, Medline Industries, and Braun SE. Strategic partnerships, acquisitions, and new product launches are common strategies. Key developments include Braun SE's collaboration with Orlando Health in March 2025 and Owen Mumford's partnership with Duopharma Biotech in February 2024.

Conclusion

The global standard pen needles market is projected to grow from USD 1.65 billion in 2025 to USD 1.74 billion in 2026, reaching USD 3.07 billion by 2034. Market growth is driven by rising diabetes prevalence, increasing insulin pen adoption, and technological advancements enhancing patient comfort. While needle phobia and limited penetration of autoinjectors present challenges, expansion in emerging markets and digital integration offer significant opportunities through 2034.

Segmentation By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Region

By Drug Type * Insulin

  • GLP-1
  • Growth Hormone
  • Others

By Disease Indication * Diabetes

  • Obesity
  • Hormone Deficiency
  • Others

By Needle Size * 4 mm

  • 5 mm
  • 6 mm
  • 8 mm
  • 12 mm

By Distribution Channel * Hospital Pharmacy

  • Retail Pharmacy
  • Online Pharmacy

By Region * North America (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country)

    • U.S.
    • Canada
  • Europe (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. New Product Launches, By Key Players
  • 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
  • 4.3. Technological Advancements in Biopharmaceutical Processing

5. Global Standard Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Drug Type
    • 5.1.1. Insulin
    • 5.1.2. GLP-1
    • 5.1.3. Growth Hormone
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Disease Indication
    • 5.2.1. Diabetes
    • 5.2.2. Obesity
    • 5.2.3. Hormone Deficiency
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Needle Size
    • 5.3.1. 4 mm
    • 5.3.2. 5 mm
    • 5.3.3. 6 mm
    • 5.3.4. 8 mm
    • 5.3.5. 12 mm
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Hospital Pharmacy
    • 5.4.2. Retail Pharmacy
    • 5.4.3. Online Pharmacy
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Standard Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Drug Type
    • 6.1.1. Insulin
    • 6.1.2. GLP-1
    • 6.1.3. Growth Hormone
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Disease Indication
    • 6.2.1. Diabetes
    • 6.2.2. Obesity
    • 6.2.3. Hormone Deficiency
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Needle Size
    • 6.3.1. 4 mm
    • 6.3.2. 5 mm
    • 6.3.3. 6 mm
    • 6.3.4. 8 mm
    • 6.3.5. 12 mm
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Hospital Pharmacy
    • 6.4.2. Retail Pharmacy
    • 6.4.3. Online Pharmacy
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Standard Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Drug Type
    • 7.1.1. Insulin
    • 7.1.2. GLP-1
    • 7.1.3. Growth Hormone
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Disease Indication
    • 7.2.1. Diabetes
    • 7.2.2. Obesity
    • 7.2.3. Hormone Deficiency
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Needle Size
    • 7.3.1. 4 mm
    • 7.3.2. 5 mm
    • 7.3.3. 6 mm
    • 7.3.4. 8 mm
    • 7.3.5. 12 mm
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Hospital Pharmacy
    • 7.4.2. Retail Pharmacy
    • 7.4.3. Online Pharmacy
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia pacific Standard Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Drug Type
    • 8.1.1. Insulin
    • 8.1.2. GLP-1
    • 8.1.3. Growth Hormone
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Disease Indication
    • 8.2.1. Diabetes
    • 8.2.2. Obesity
    • 8.2.3. Hormone Deficiency
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Needle Size
    • 8.3.1. 4 mm
    • 8.3.2. 5 mm
    • 8.3.3. 6 mm
    • 8.3.4. 8 mm
    • 8.3.5. 12 mm
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Hospital Pharmacy
    • 8.4.2. Retail Pharmacy
    • 8.4.3. Online Pharmacy
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Standard Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Drug Type
    • 9.1.1. Insulin
    • 9.1.2. GLP-1
    • 9.1.3. Growth Hormone
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Disease Indication
    • 9.2.1. Diabetes
    • 9.2.2. Obesity
    • 9.2.3. Hormone Deficiency
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Needle Size
    • 9.3.1. 4 mm
    • 9.3.2. 5 mm
    • 9.3.3. 6 mm
    • 9.3.4. 8 mm
    • 9.3.5. 12 mm
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Hospital Pharmacy
    • 9.4.2. Retail Pharmacy
    • 9.4.3. Online Pharmacy
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Standard Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Drug Type
    • 10.1.1. Insulin
    • 10.1.2. GLP-1
    • 10.1.3. Growth Hormone
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Disease Indication
    • 10.2.1. Diabetes
    • 10.2.2. Obesity
    • 10.2.3. Hormone Deficiency
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Needle Size
    • 10.3.1. 4 mm
    • 10.3.2. 5 mm
    • 10.3.3. 6 mm
    • 10.3.4. 8 mm
    • 10.3.5. 12 mm
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Hospital Pharmacy
    • 10.4.2. Retail Pharmacy
    • 10.4.3. Online Pharmacy
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
    • 11.2.1. Embecta Corp.
    • 11.2.2. Cardinal Health
    • 11.2.3. MTD Medical Technology and Devices
    • 11.2.4. UltiMed, Inc.
    • 11.2.5. Allison Medical, Inc.
    • 11.2.6. Owen Mumford
    • 11.2.7. Medline Industries, LP
    • 11.2.8. B. Braun SE
    • 11.2.9. Neon Diagnostics Limited
    • 11.2.10. Other Prominent Players

List of Tables

  • Table 1: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 2: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 3: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 4: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 5: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 7: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 8: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 9: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 10: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 11: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 12: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 13: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 14: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 15: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034
  • Table 16: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 17: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 18: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 19: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 20: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034
  • Table 21: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 22: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 23: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 24: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 25: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034
  • Table 26: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 27: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 28: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 29: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 30: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Standard Pen Needles Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Standard Pen Needles Market Value Share (%), by Drug Type, 2025 & 2034
  • Figure 3: Global Standard Pen Needles Market Value Share (%), by Disease Indication, 2025 & 2034
  • Figure 4: Global Standard Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 5: Global Standard Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 6: Global Standard Pen Needles Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Standard Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 8: North America Standard Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 9: North America Standard Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 10: North America Standard Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 11: North America Standard Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 12: North America Standard Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 13: North America Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: North America Standard Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: North America Standard Pen Needles Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Standard Pen Needles Market Value Share (%), By Country, 2025
  • Figure 17: Europe Standard Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 18: Europe Standard Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 19: Europe Standard Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 20: Europe Standard Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 21: Europe Standard Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 22: Europe Standard Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 23: Europe Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 24: Europe Standard Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 25: Europe Standard Pen Needles Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 26: Europe Standard Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 27: Asia Pacific Standard Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 28: Asia Pacific Standard Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 29: Asia Pacific Standard Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 30: Asia Pacific Standard Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 31: Asia Pacific Standard Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 32: Asia Pacific Standard Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 33: Asia Pacific Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 34: Asia Pacific Standard Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 35: Asia Pacific Standard Pen Needles Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Standard Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 37: Latin America Standard Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 38: Latin America Standard Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 39: Latin America Standard Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 40: Latin America Standard Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 41: Latin America Standard Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 42: Latin America Standard Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 43: Latin America Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 44: Latin America Standard Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 45: Latin America Standard Pen Needles Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 46: Latin America Standard Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 47: Middle East & Africa Standard Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 48: Middle East & Africa Standard Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 49: Middle East & Africa Standard Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 50: Middle East & Africa Standard Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 51: Middle East & Africa Standard Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 52: Middle East & Africa Standard Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 53: Middle East & Africa Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 54: Middle East & Africa Standard Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 55: Middle East & Africa Standard Pen Needles Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Standard Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 57: Global Standard Pen Needles Market Share (%), 2025